Fingerprint
Dive into the research topics of 'Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: Phase II MCL-001 (EMERGE) study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically